Abstract | BACKGROUND: AIMS: To investigate the distribution of HLA-DQ and the related risks of CD development in Northwest China. METHODS: A total of 75 CD patients and 300 healthy individuals were genotyped for HLA-DQ using the Illumina NextSeq, and the relative risks of the different genotypes were evaluated. RESULTS: In total, 68.00% of CD patients and 21.00% of controls carried HLA-DQ2.5 heterodimers (p < 0.001). We identified four CD risk gradients. Individuals carrying a double dose of DQB1*02 had the highest risk of developing CD (1:16); however, with heterozygosis (DQB1*02:02/DQB1*02:01) having the highest risk (1:9). HLA-DQ2.5 individuals with a single copy of HLA-DQB1*02, in either the cis or trans configuration, were at a medium risk (1:38). Non-DQ2.5 carriers of DQ8 or DQ2.2 were at low risk, while only carriers of DQ7.5 or DQX.5 were at very low risk. Patients with the HLA-DQ2.5 genotype had more severe mucosal damage compared with the HLA-DQ2.5 genotype negative CD patients (70.59% vs. 41.67%, p = 0.016). CONCLUSION:
Genetic susceptibility to CD is highly prevalent in the Northwest Chinese population and the highest risk of developing CD was associated with the DQ2.5/DQ2.2 genotype. The DQ2.5 allele is involved in the severity of mucosal injury.
|
Authors | Tian Shi, Weidong Liu, Ting Li, Huan Liu, Wenjia Hui, Qiang Lin, Xiaojiang Han, Feng Gao |
Journal | Scandinavian journal of gastroenterology
(Scand J Gastroenterol)
Vol. 58
Issue 5
Pg. 471-476
(05 2023)
ISSN: 1502-7708 [Electronic] England |
PMID | 36415137
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Humans
- Genetic Predisposition to Disease
- Celiac Disease
(complications)
- Genotype
- HLA-DQ Antigens
(genetics)
- Haplotypes
- Inflammatory Bowel Diseases
(complications)
- China
(epidemiology)
|